GC38774
DRF-1042
Also known as (19S)-19-ethyl-19-hydroxy-12-(2-hydroxyethoxy)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
DRF-1042 is an orally active derivative of Camptothecin· DRF-1042 acts to inhibit DNA topoisomerase I· DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-drug resistance (MDR) phenotype
ChemicalCAS200619-13-2MW408.4FormulaC22H20N2O6
- CAS number
- 200619-13-2
- Molecular weight
- 408.4
- Formula
- C22H20N2O6
- Solubility
- DMSO： 50 mg/mL (122·43 mM)
- InChIKey
- XAKLYHGHEFMDAP-IAXKEJLGSA-N
- Catalogue number
- GC38774
- Brand
- GLPBIO
Computed properties PubChem CID 23631031 · XLogP 0.3 · TPSA 109 Ų · H-bond donors 2
- XLogP
- 0.3
- TPSA
- 109 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 30
SMILES CC[C@@]1(C2=C(COC1=O)C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)O
Computed descriptors from PubChem (CID 23631031), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il